NEET-PG 2015 - Community Medicine Practice Questions

Q: What is the primary benefit of screening for diseases?

Early detection of diseases. ***Early detection of diseases*** - This is the **primary benefit** and defining purpose of **screening programs** in public health. - Screening identifies diseases in their **presymptomatic or early stage** when individuals are apparently healthy, allowing for intervention before clinical symptoms appear. - According to epidemiological principles, the goal of screening is to detect disease **earlier than it would be found through routine clinical practice**. - Early detection enables better prognosis through **lead time** and **length time bias** advantages. *Timely treatment of identified conditions* - While treatment is the **ultimate goal** of healthcare, it is not specific to screening—treatment occurs whether disease is found through screening or clinical presentation. - Treatment is the **consequence** of early detection, not the primary benefit of the screening process itself. - The unique value of screening lies in **detection**, not treatment per se. *Providing support for patients after diagnosis* - **Patient support** is an important aspect of healthcare but is not the purpose of screening programs. - This is **post-diagnostic care**, which follows after the screening process has identified cases. *Identifying all potential cases of a disease* - **Screening tests** cannot identify all cases due to inherent limitations in **sensitivity** and **specificity**. - Screening aims to identify a significant proportion of cases in a population, accepting that some will be missed (**false negatives**) and some healthy individuals may test positive (**false positives**).

Q: Which of the following is not true about the Vi polysaccharide vaccine for typhoid?

Given at birth. ***Given at birth*** - The **typhoid Vi polysaccharide vaccine is not administered at birth**. It is recommended for individuals **2 years of age**. - Vaccines given at birth protect against diseases with significant **neonatal risk**, such as Hepatitis B and BCG (tuberculosis). - This is the **FALSE** statement, making it the correct answer to this "not true" question. *Single dose is given* - The Vi polysaccharide vaccine is administered as a **single 0.5 mL dose**. - This single dose provides protection against *Salmonella typhi* for approximately 3 years. - This statement is **TRUE**. *Revaccination at 3 years* - For ongoing protection, **revaccination is recommended every 3 years** for individuals at continued risk of typhoid exposure. - The booster dose maintains adequate protective antibody levels. - This statement is **TRUE**. *Given intramuscularly* - The Vi polysaccharide vaccine is administered via the **intramuscular (IM) route**, typically in the deltoid muscle. - This is the standard recommended route of administration. - This statement is **TRUE**.

Q: Human, animal, fomite or objects from which infective organism enters the host is called?

Source of infection. ***Source of infection*** - The **source of infection** refers to the person, animal, object, or substance from which an infectious agent passes immediately to a host. - This can include humans, animals, fomites, or contaminated objects that directly transmit the infectious organism. - This is the proximate source from which the agent enters the host. *Infective Reservoir* - An **infective reservoir** is the long-term habitat where an infectious agent normally lives, grows, and multiplies. - The reservoir can be human, animal, plant, soil, or inanimate matter where the agent is normally found. - While a reservoir can be a source, the source is specifically the immediate point from which transmission occurs. *Infective Carrier* - An **infective carrier** is an infected person or animal that harbors a specific infectious agent without showing clinical symptoms but can transmit it to others. - A carrier is a type of source (when transmission occurs from them), but the term "source" is broader, encompassing inanimate objects and fomites as well. *None of the above* - This option is incorrect because **Source of infection** accurately describes the concept presented in the question.

Q: Most commonly used blinding technique in epidemiological studies?

Double blinding. ***Double blinding*** - In **double blinding**, neither the **participants** nor the **researchers** administering the intervention and collecting data know who is in the treatment group versus the control group. - This method is widely used to prevent **observer bias** from the researchers and **participant bias** (e.g., placebo effect) from the subjects, thereby strengthening the study's internal validity. *Single blinding* - In **single blinding**, only the **participants** are unaware of their assignment to either the treatment or control group. - While it helps reduce participant bias, the **researchers' knowledge** of group assignments can still introduce **observer bias**, making it less rigorous than double blinding. *Triple blinding* - **Triple blinding** extends double blinding by ensuring that the **data analysts** are also unaware of the participant group assignments. - This technique further minimizes bias in the **interpretation and analysis of results**, but it is less commonly implemented due to its complexity and increased logistical challenges compared to double blinding. *None of the options* - This option is incorrect because **blinding techniques** are fundamental tools in epidemiological studies and clinical trials to ensure the objectivity and reliability of research findings. - **Blinding** helps eliminate conscious and unconscious biases that could otherwise influence study outcomes.

Q: What is a key benefit of Randomized Controlled Trials (RCTs) in clinical research?

They minimize selection bias.. ***They minimize selection bias.*** - **Randomization** in RCTs ensures that participants have an equal chance of being assigned to any of the treatment groups, thereby balancing potential **confounding factors** across groups. - This balance helps to ensure that any observed differences in outcomes between groups are more likely due to the intervention being studied rather than pre-existing differences among participants, thus minimizing **selection bias**. *They can be conducted more quickly than other study types.* - RCTs often require **extensive planning**, recruitment, and follow-up periods, making them one of the **most time-consuming** study designs. - The need for sufficient **power** to detect meaningful differences often translates into longer study durations. *They are ideal for studying rare diseases.* - Due to the requirement for **large sample sizes** to demonstrate statistical significance, RCTs are **not practical** for diseases with low prevalence. - Recruiting enough participants with a rare disease for an RCT can be extremely challenging and often **unfeasible**. *They are generally less expensive than other study types.* - RCTs are typically among the **most expensive** study designs because they involve extensive participant recruitment, intervention administration, data collection, and long-term follow-up. - The costs associated with staff, resources, and monitoring for ethical compliance contribute to their **high financial burden**.

Q: Which one of the following is NOT a utilization rate?

Population bed ratio. ***Population bed ratio*** - The **population bed ratio** indicates the number of available beds per unit of population, reflecting healthcare **resource availability** rather than resource utilization. - It is a measure of healthcare capacity and access, not how intensively those beds are being used. *Bed occupancy rate* - The **bed occupancy rate** measures the proportion of available hospital beds that are occupied over a given period, directly indicating the **utilization** of bed resources. - A higher rate suggests more efficient use of beds, while a lower rate may indicate underutilization or excess capacity. *Bed turnover ratio* - The **bed turnover ratio** calculates the number of patients discharged per bed over a specific period, reflecting how frequently beds are being used and re-used. - It indicates the **efficiency** with which beds are being utilized and cleared for new patients. *Average length of stay* - The **average length of stay (ALOS)** represents the average number of days a patient remains hospitalized, which directly relates to the **duration of bed utilization** per patient. - A shorter ALOS can indicate more efficient use of beds, while a longer ALOS may suggest higher resource consumption per patient.

Q: What is the range of values for the Physical Quality of Life Index (PQLI)?

0 to 100. ***0 to 100*** - The **Physical Quality of Life Index (PQLI)** is an index that measures the quality of life or well-being of a country, with values ranging from **0 (worst)** to **100 (best)**. - This standardized range allows for easy comparison of living standards and societal progress across different nations. *0 to 10* - This range is too small and does not accurately represent the comprehensive scoring system used for the **PQLI**, which aggregates multiple indicators. - While some individual metrics might use a 0-10 scale, the composite PQLI itself uses a broader range. *0 to 50* - This range is insufficient to capture the full spectrum of development indicators factored into the **PQLI**. - A maximum value of 50 would compress the data too much, making fine distinctions between countries less apparent. *100 to 200* - The **PQLI** is capped at 100, which signifies the highest possible quality of life; therefore, values above 100 are not possible. - This range suggests an overly optimistic or unstandardized index, which is not the case for PQLI.

Question 1

What is the definition of a reservoir in the context of infectious diseases?

Accepted Answer

Person, animal or substance in which infectious agent lives and multiplies

Answer

Person, animal or object from which infectious agent is transmitted to host

Answer

Person or animal in which infectious agent causes a disease

Answer

Person or animal that transmits the infectious agent mechanically

Question 2

What is the primary benefit of screening for diseases?

Accepted Answer

Early detection of diseases

Answer

Providing support for patients after diagnosis

Answer

Identifying all potential cases of a disease

Answer

Timely treatment of identified conditions

Question 3

Multiphasic screening means-

Accepted Answer

Application of two or more screening tests in combination at one time

Answer

Application of two or more screening tests in combination at different geographical areas

Answer

Application of separate screening tests for different diseases

Answer

Application of two or more screening tests in combination at different times

Question 4

Which of the following is not true about the Vi polysaccharide vaccine for typhoid?

Accepted Answer

Given at birth

Answer

Given intramuscularly

Answer

Revaccination at 3 years

Answer

Single dose is given

Question 5

Human, animal, fomite or objects from which infective organism enters the host is called?

Accepted Answer

Source of infection

Answer

Infective Reservoir

Answer

Infective Carrier

Answer

None of the above

Question 6

Most commonly used blinding technique in epidemiological studies?

Accepted Answer

Double blinding

Answer

None of the options

Answer

Single blinding

Answer

Triple blinding

Question 7

What is a key benefit of Randomized Controlled Trials (RCTs) in clinical research?

Accepted Answer

They minimize selection bias.

Answer

They can be conducted more quickly than other study types.

Answer

They are ideal for studying rare diseases.

Answer

They are generally less expensive than other study types.

Question 8

Which one of the following is NOT a utilization rate?

Accepted Answer

Population bed ratio

Answer

Bed occupancy rate

Answer

Bed turnover ratio

Answer

Average length of stay

Question 9

Which of the following statements is true regarding a combined prospective-retrospective study?

Accepted Answer

Retrospective identification of cohort followed by prospective follow-up

Answer

Only prospective follow-up from current time point

Answer

Cross-sectional assessment at a single time point

Answer

Only retrospective data collection from past records

Question 10

What is the range of values for the Physical Quality of Life Index (PQLI)?

Accepted Answer

0 to 100

Answer

0 to 10

Answer

0 to 50

Answer

100 to 200

NEET-PG 2015 — Community Medicine